Empresa SYNLAB AG Deutsche Boerse AG
Acciones
SYAB
DE000A2TSL71
Instalaciones y servicios de atención médica
Mercado cerrado -
Otros sitios de cotización
|
Después de cerrar 20:55:15 | |||
10,56 EUR | -1,86 % | 10,6 | +0,38 % |
25/03 | Panorama Dpa-AFX: EMPRESAS del 25/03/2024 - 15:15 | DP |
25/03 | Transcript : SYNLAB AG, 2023 Earnings Call, Mar 25, 2024 |
Resumen de negocios
Número de empleados: 23 538
Ventas por actividad
EUR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Human Medicine
97,6
%
| 3 168 | 97,5 % | 2 572 | 97,6 % | -18,79 % |
Veterinary Medicine
1,1
%
| 42 | 1,3 % | 29 | 1,1 % | -29,98 % |
Trading Goods and Services
0,7
%
| 20 | 0,6 % | 20 | 0,7 % | -1,03 % |
Environmental and Other Analysis, Studies, Expertise
0,3
%
| 10 | 0,3 % | 9 | 0,3 % | -10,26 % |
Software Solutions and Services
0,2
%
| 12 | 0,4 % | 6 | 0,2 % | -53,57 % |
Ventas por región
EUR en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Germany
20,3
%
| 703 | 21,6 % | 536 | 20,3 % | -23,75 % |
France
19,9
%
| 674 | 20,7 % | 524 | 19,9 % | -22,24 % |
South
17,5
%
| 0 | 0,0 % | 461 | 17,5 % | - |
Italy
13,0
%
| 355 | 10,9 % | 343 | 13,0 % | -3,59 % |
United Kingdom
13,0
%
| - | - | 343 | 13,0 % | - |
North & East
8,3
%
| 913 | 28,1 % | 217 | 8,3 % | -76,17 % |
Latin America
8,0
%
| 192 | 5,9 % | 211 | 8,0 % | +9,76 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Mathieu Floreani
CEO | Chief Executive Officer | 56 | 26/01/21 |
Sami Badarani
DFI | Director of Finance/CFO | 61 | 26/01/21 |
Henrik Andreasen
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | 40 | - | |
Chief Tech/Sci/R&D Officer | - | - | |
Mark Reinhard
IRC | Investor Relations Contact | - | 01/01/21 |
Walla Fabian
SEC | Corporate Secretary | - | - |
Human Resources Officer | - | - | |
Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
David Ebsworth
CHM | Chairman | 69 | 11/01/21 |
Founder | 63 | 01/01/98 | |
Peter Catterall
BRD | Director/Board Member | 55 | 11/01/21 |
Marc Welters
BRD | Director/Board Member | - | 29/04/21 |
Director/Board Member | 50 | 29/04/21 | |
Barbara Lambert
BRD | Director/Board Member | 62 | 11/01/21 |
Karin Bierstedt
BRD | Director/Board Member | 52 | 29/04/21 |
Stefan Graf
BRD | Director/Board Member | 65 | 29/04/21 |
Ute Hasholzner
BRD | Director/Board Member | 65 | 29/04/21 |
Director/Board Member | - | 29/04/21 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 222 222 222 | 76 278 423 ( 34,33 %) | 2 447 000 ( 1,101 %) | 34,33 % |
Participaciones
Nombre | Acciones | % | Valoración |
---|---|---|---|
SYNLAB AG 1.13% | 2 518 864 | 1.13% | 29 788 086 $ |
Información de la empresa
Empresas del grupo
Nombre | Categoría y sector |
---|---|
SYNLAB Bondco Plc
SYNLAB Bondco Plc Financial ConglomeratesFinance SYNLAB Bondco Plc offers medical diagnostics for patients, practicing doctors, clinics and the pharmaceutical industry. The company was founded on March 23, 2015 and is headquartered in London, the United Kingdom. |
Financial Conglomerates
|
Sector
Ventas por actividad
Ventas por región
Revisiones del BPA
Ganancias trimestrales - Tasa de sorpresa
Varia. 1 de ene. | Capi. | |
---|---|---|
-18,98 % | 8149,9 M | |
+37,47 % | 3529,87 M | |
-26,35 % | 3023,08 M | |
-9,71 % | 2309,95 M | |
-15,45 % | 1768,17 M | |
-23,06 % | 1452,78 M | |
-38,05 % | 1255,42 M | |
-11,04 % | 1140,41 M | |
+4,07 % | 1069,2 M |
- Bolsa de valores
- Acciones
- Acción SYAB
- Acción SYAB
- Empresa SYNLAB AG